Anti-Tumor Necrosis Factor-Alpha (TNF-#945;) Treatment Strategies in Crohns Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-2710|1|1|21-34

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.1, Iss.1, 2007-02, pp. : 21-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Method of Inhibition of Activity of Tumor Necrosis Factor Alpha In Patients with Psoriasis

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 10, Iss. 1, 2016-10 ,pp. : 63-66

Bentham Science Publishers

Access to resources Recommend Favorite

Infectious Complications with Anti-TNF#945; Therapy in Rheumatic Diseases: A Review

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 1, 2007-02 ,pp. : 39-47

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor Inhibitors in Pediatric Asthma

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 2, 2009-01 ,pp. : 143-148

Bentham Science Publishers

Access to resources Recommend Favorite

TNF-Alpha Antagonism in Severe Asthma?

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 193-200

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 1, 2009-01 ,pp. : 1-16

Bentham Science Publishers

Access to resources Recommend Favorite